The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis
Open accessAbstract
Rationale: Lung transplantation offers the only survival option for patients with cystic fibrosis (CF) with end-stage pulmonary disease. Infection with Burkholderia species is typically considered a contraindication to transplantation in CF. However, the risks posed by different Burkholderia species on transplantation outcomes are poorly defined. Objectives: To quantify the risks of infection with Burkholderia species on survival before and after lung transplantation in patients with CF. Methods: Multivariate Cox survival models assessed hazard ratios of infection with Burkholderia species in 1,026 lung transplant candidates and 528 lung transplant recipients. Lung allocation scores, incorporating Burkholderia infection status, were calculated for transplant candidates. Measurements and Main Results: Transplant candidates infected with different Burkholderia species did not have statistically different mortality rates. Among transplant recipients infected with B. cenocepacia, only those infected with nonepidemic strains had significantly greater post-transplant mortality compared with uninfected patients (hazard ratio [HR], 2.52; 95% confidence interval [CI], 1.04–6.12; P = 0.04). Hazards were similar between uninfected transplant recipients and those infected with B. multivorans (HR, 0.66; 95% CI, 0.27–1.56; P = 0.34). Transplant recipients infected with B. gladioli had significantly greater post-transplant mortality than uninfected patients (HR, 2.23; 95% CI, 1.05–4.74; P = 0.04). Once hazards for species/strain were included, lung allocation scores of B. multivorans–infected transplant candidates were comparable to uninfected candidate scores, whereas those of candidates infected with nonepidemic B. cenocepacia or B. gladioli were lower. Conclusions: Post-transplant mortality among patients with CF infected with Burkholderia varies by infecting species. This variability should be taken into account in evaluating lung transplantation candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“particularly B. cenocepacia has been associated with post-transplant infections and increased mortality especially within the first 6–12 months.(72, 73)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [73]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Development of the New Lung Allocation System in the United States
Egan, T. M., Murray, S., Bustami, R. T., Shearon, T. H., McCullough, K. P., Edwards, L. B., Coke, M. A., Garrity, E. R., Sweet, S. C., Heiney, D. A., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01276.x · Cited by 767
Self-citationMahenthiralingam, E., Bischof, J. M., Byrne, S. K., Radomski, C. C. A., DAVIES, J. E., Av‐Gay, Y., & Vandamme, P. A. R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3165-3173.2000 · Cited by 499
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
Hosenpud, J. D., Bennett, L. E., Keck, B. M., Edwards, E. B., & Novick, R. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06405-2 · Cited by 472
Lung Transplantation for Cystic Fibrosis Patients with Burkholderia cepacia Complex
Aris, R. M., ROUTH, J. C., LiPuma, J. J., Heath, D. G., & Gilligan, P. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2107022 · Cited by 255
Self-citationBurkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis
Jones, A. M. (2004) · Thorax · doi:10.1136/thx.2003.017210 · Cited by 251
Infection with Burkholderia cepacia in Cystic Fibrosis
Chaparro, C., MAURER, J. R., GUTIERREZ, C., Krajden, M., CHAN, C., Winton, T. L., Keshavjee, S. H., Scavuzzo, M., Tullis, E. D., Hutcheon, M., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.9811076 · Cited by 232
Update on the Burkholderia cepacia complex
LiPuma, J. J. (2005) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000181475.85187.ed · Cited by 217
Self-citationLung Transplantation and Survival in Children with Cystic Fibrosis
Liou, T. G., Adler, F. R., Cox, D. R., & Cahill, B. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066359 · Cited by 196
Survival Effect of Lung Transplantation Among Patients With Cystic Fibrosis
Liou, T. G. (2001) · JAMA · doi:10.1001/jama.286.21.2683 · Cited by 174
Pseudomonas cepacia in Lung Transplant Recipients With Cystic Fibrosis
Snell, G. I., de Hoyos, A., Krajden, M., Winton, T. L., & MAURER, J. R. (1993) · CHEST Journal · doi:10.1378/chest.103.2.466 · Cited by 165
Reik, R., Spilker, T., & LiPuma, J. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2926-2928.2005 · Cited by 160
Self-citationLiPuma, J. J., Dulaney, B. J., McMenamin, J. D., Whitby, P. W., Stull, T. L., Coenye, T., & Vandamme, P. A. R. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3167-3170.1999 · Cited by 159
Self-citationSoyza, A. D., McDowell, A., Archer, L., Dark, J. H., Elborn, J. S., Mahenthiralingam, E., Gould, K., & Corris, P. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06808-8 · Cited by 158
Govan, J. R. W., Brown, A. R., & Jones, A. M. (2007) · Future Microbiology · doi:10.2217/17460913.2.2.153 · Cited by 157
Segonds, C., Heulin, T., Marty, N., & Chabanon, G. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2201-2208.1999 · Cited by 143
The Effects of Panresistant Bacteria in Cystic Fibrosis Patients on Lung Transplant Outcome
Aris, R. M., Gilligan, P. H., Neuringer, I. P., Gott, K., Rea, J., & Yankaskas, J. R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154879 · Cited by 142
A Decade of Lung Transplantation
Griffith, B. P., Hardesty, R. L., Armitage, J. M., Hattler, B. G. J., Pham, S. M., Keenan, R. J., & Paradis, I. L. (1993) · Annals of Surgery · doi:10.1097/00000658-199309000-00010 · Cited by 139
Coenye, T., Spilker, T., Martin, A., & LiPuma, J. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3300-3307.2002 · Cited by 132
Self-citationUse of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis
Liou, T. G., Adler, F. R., & Huang, D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-900oc · Cited by 131
Whiteford, M. L., Wilkinson, J. D., McColl, J. H., Conlon, F. M., Michie, J. R., Evans, T. J., & Paton, J. Y. (1995) · Thorax · doi:10.1136/thx.50.11.1194 · Cited by 130
Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis
Chen, J. S., Witzmann, K. A., Spilker, T., Fink, R. J., & LiPuma, J. J. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.118430 · Cited by 124
Self-citationLung transplantation and life extension in children with cystic fibrosis
Aurora, P., Whitehead, B., Wade, A. M., Bowyer, J., Whitmore, P. M., Rees, P. G., Tsang, V. T., Elliott, M. J., & de Leval, M. R. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03031-7 · Cited by 112
Misidentification of Burkholderia cepacia in US Cystic Fibrosis Treatment Centers
McMenamin, J. D., Zaccone, T. M., Coenye, T., Vandamme, P. A. R., & LiPuma, J. J. (2000) · CHEST Journal · doi:10.1378/chest.117.6.1661 · Cited by 110
Self-citationInfections in Patients With Cystic Fibrosis Following Lung Transplantation
Kanj, S. S., Tapson, V. F., Davis, R. D., Madden, J., & Browning, I. (1997) · CHEST Journal · doi:10.1378/chest.112.4.924 · Cited by 106
Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre
Ledson, M. J. (2002) · Thorax · doi:10.1136/thorax.57.2.142 · Cited by 103
Bronchiolitis Obliterans Organizing Pneumonia (BOOP) in Lung Transplant Recipients
Chaparro, C., Chamberlain, D. W., Maurer, J., Winton, T. L., DeHoyos, A., & Kesten, S. (1996) · CHEST Journal · doi:10.1378/chest.110.5.1150 · Cited by 74
Burkholderia gladioli: Five year experience in a cystic fibrosis and lung transplantation center
Kennedy, M. P., Coakley, R. D., Donaldson, S. H., Aris, R. M., Hohneker, K., Wedd, J. P., Knowles, M. R., Gilligan, P. H., & Yankaskas, J. R. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.10.007 · Cited by 73
Coenye, T. (2003) · Microbiology · doi:10.1099/mic.0.25850-0 · Cited by 70
Double-lung transplantation in mechanically ventilated patients with cystic fibrosis
Massard, G., Shennib, H., Metras, D. R., Camboulives, J., Viard, L., Mulder, D. S., Tchervenkov, C. I., Morin, J., Giudicelli, R., & Noirclerc, M. (1993) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(93)90012-7 · Cited by 63
Timing of Referral for Lung Transplantation for Cystic Fibrosis
Doershuk, C. F., & Stern, R. C. (1999) · CHEST Journal · doi:10.1378/chest.115.3.782 · Cited by 55
Burkholderia cepaciacomplex: a contraindication to lung transplantation in cystic fibrosis?
LiPuma, J. J. (2001) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2001.003003149.x · Cited by 47
Self-citationNoyes, B. E., Michaels, M. G., Kurland, G., Armitage, J. M., & Orenstein, D. M. (1994) · CHEST Journal · doi:10.1378/chest.105.6.1888 · Cited by 47
Khan, S. U. Z., Gordon, S. M., Stillwell, P. C., Kirby, T. J., & Arroliga, A. C. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199607000-00020 · Cited by 43
Burkholderia gladioli:Recurrent Abscesses in a Patient with Cystic Fibrosis
Jones, A. M., Stanbridge, T. N., Isalska, B. J., Dodd, M. E., & Webb, A. K. (2001) · Journal of Infection · doi:10.1053/jinf.2000.0770 · Cited by 27
Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia
Egan, J. J., McNeil, K., Bookless, B., Gould, K., Corris, P. A., Higenbottam, T., Webb, A. K., & Woodcock, A. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91950-x · Cited by 25
Webb, A. K., & Egan, J. J. (1997) · Thorax · doi:10.1136/thx.52.8.671 · Cited by 20
Complications of pediatric lung and heart-lung transplantation
Kurland, G., & Orenstein, D. M. (1994) · Current Opinion in Pediatrics · doi:10.1097/00008480-199406000-00006 · Cited by 19
Balfour-Lynn, I. M., Ryley, H. C., & Whitehead, B. (1997) · Journal of the Royal Society of Medicine · doi:10.1177/014107689709031s11 · Cited by 16
Research works printed but not linked: 6
- 2007, Am J Transplant, 7, 244
- 1994, Curr Opin Pediatr, 6, 262
- 1997, J R Soc Med, 90, 59
- 1972, J Roy Stat Soc[Ser A], 34, 187
- 2000, Am J Respir Crit Care Med, 161, A720
- 2002, Microbiology, 149, 77
Cited by
Sorted by citations
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
“cenocepacia has been associated with post-transplant infections and increased mortality especially within the first 6-12 months.(72,73) While it may be considered an absolute contraindication at many centers, patients may be candidates at specialized centers that have attained satisfactory outcomes with protocols impl…”
BackgroundClinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar‐Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 435
Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Saiman, L. M., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J. D., Hazle, L., Jain, M., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/676882 · Cited by 405
Self-citationKotloff, R. M., & Thabut, G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0134ci · Cited by 255
“The observed excessive post-transplant mortality appears largely attributable to Burkholderia cenocepacia (genomovar III) and to a lesser extent, Burkholderia gladioli (18, 19).”
Metadata
- Authors
- Murray, S., Charbeneau, J., Marshall, B. C., & LiPuma, J. J.
- Affiliations
- University of Michigan (US)
- Cystic Fibrosis Foundation (US)
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-08
- Volume
- 178
- Issue
- 4
- Pages
- 363-371
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2081925747
- Semantic Scholar
- 68cf39ee60f9774eb35ae3f703478d0c836ebf29
- Cited by
- 177
- References
- 40
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 10 · 2020: 13 · 2019: 9 · 2018: 9 · 2017: 12 · 2016: 9 · 2015: 13 · 2014: 14 · 2013: 8 · 2012: 12
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- Cystic Fibrosis Foundation
- Health Resources and Services Administration
- Topics
- Health Sciences › Medicine › Epidemiology › Burkholderia infections and melioidosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- cystic fibrosis, lung transplantation, Burkholderia cenocepacia, Burkholderia multivorans, Burkholderia gladioli, post-transplant mortality, lung allocation score, transplant candidates
- MeSH terms
- Contraindications, Adult, Cystic Fibrosis, Female, Humans, Male, Postoperative Complications, Prognosis, Risk, United States, Cohort Studies, Survival Rate, Multivariate Analysis, Case-Control Studies, Lung Transplantation, Treatment Outcome, Pneumonia, Bacterial, Disease-Free Survival, Burkholderia Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
